Market Share of Europe Cancer Biomarkers Industry
The European cancer biomarkers market is highly competitive and consists of a few major players. Some companies currently dominating the market include Abbott Laboratories Inc., Agilent Technologies, Ambry Genetics, Biomerieux, Celera Corporation (Quest Diagnostics), F. Hoffmann-La Roche Ltd, Hologic Inc., Illumina Inc., and Thermo Fisher Scientific. Furthermore, some of the major market players, such as Novartis and Gilead in cancer therapy, are from Europe, one of the factors boosting the R&D activities in the region.
Europe Cancer Biomarkers Market Leaders
-
Abbott Laboratories Inc
-
F. Hoffmann-La Roche Ltd
-
Illumina Inc
-
Thermo Fisher Scientific
-
Biomerieux
*Disclaimer: Major Players sorted in no particular order
